Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 17-24, January 2010

The Restoration of Chronotropic CompEtence in Heart Failure PatientS with Normal Ejection FracTion (RESET) Study: Rationale and Design

  • David A. Kass, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions Baltimore, MD
    • Corresponding Author InformationReprint requests: David A. Kass, MD, Ross 858, Division of Cardiology, Johns Hopkins University Medical Institutions, 720 Rutland Avenue, Baltimore, MD 21205. Tel: (410) 955-7153; Fax: (410) 502-2558.
    • ,
  • Dalane W. Kitzman, MD

      Affiliations

    • Sections of Cardiology and Geriatrics, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC
    • ,
  • Guy E. Alvarez, PhD

      Affiliations

    • Boston Scientific CRM, St. Paul, MN

Received 15 June 2009; received in revised form 12 August 2009; accepted 17 August 2009. published online 08 October 2009.

Abstract 

Background

Heart failure with preserved ejection fraction (HFpEF) is the predominant form of heart failure among the elderly and in women. However, there are few if any evidence-based therapeutic options for HFpEF. The chief complaint of HFpEF is reduced tolerance to physical exertion. Recent data revealed that 1 potential mechanism of exertional intolerance in HFpEF patients is inadequate chronotropic response. Although there is considerable evidence demonstrating the benefits of rate-adaptive pacing (RAP) provided from implantable cardiac devices in patients with an impaired chronotropic response, the effect of RAP in HFpEF is unknown.

Methods and Results

The Restoration of Chronotropic CompEtence in Heart Failure PatientS with Normal Ejection FracTion (RESET) study is a prospective, multicenter, double-blind, randomized with stratification, study assessing the effect of RAP on peak oxygen consumption and quality of life. RAP therapy will be evaluated in a crossover paired fashion for each patient within each study stratum. Study strata are based on patient β-blocker usage at time of enrollment. The study is powered to assess the impact of pacing independently in both strata.

Conclusions

The RESET study seeks to evaluate the potential benefit of RAP in patients with symptomatic mild to moderate HFpEF and chronotropic impairment. Study enrollment began in July 2008.

Key Words: Heart failure, heart rate, diastole, ejection fraction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Drs. Kass and Kitzman have received honoraria as consultants from Boston Scientific CRM. Dr. Alvarez is an employee of Boston Scientific CRM.

PII: S1071-9164(09)01036-7

doi:10.1016/j.cardfail.2009.08.008

Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 17-24, January 2010

Article Tools

* Image Usage & Resolution